A Phase 1 Multicenter Study Evaluating the Safety and Tolerability of GCC19CART for Subjects With Relapsed or Refractory Metastatic Colorectal Cancer

Disease Name: 
Colorectal Cancer
Study Status: 
Date: 
April 25, 2023